Physician profile
Emmanuel Eisenstein
NPI 1831451913
$22,243.55
in general payments reported to CMS, 2019-2025
8 companies · $6,033 in 2025
The $6,033 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,115 · 2021: $894 · 2022: $2,190 · 2023: $3,331 · 2024: $7,680 · 2025: $6,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,202 · Travel and Lodging: $7,843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,201.70 |
| Travel and Lodging | $7,842.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $15,110.61 | 2019-2025 | Pro, Gamma, Mako |
| Zimmer Biomet Holdings, INC. | $2,799.99 | 2024-2025 | Persona, Oss Orthopedic Salvage System, Rosa |
| Smith+Nephew, INC. | $2,391.22 | 2019-2025 | Journey II, Legion Revision, Redapt |
| Pylant Medical | $1,325.23 | 2022-2024 | |
| Foundation Medical, LLC | $292.71 | 2024-2025 | |
| Depuy Synthes Sales INC. | $264.22 | 2024-2025 | Na |
| Bioventus LLC | $36.59 | 2025 | Exogen Ultrasound Bone Healing System |
| Avanos Medical | $22.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmanuel Eisenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.